| 11/16/2026 4:04 PM | Amylyx Pharmaceuticals (1658551) Subject PERCEPTIVE ADVISORS LLC (1224962) Filed by | Form SCHEDULE 13G/A | |
| 11/09/2026 3:36 PM | Amylyx Pharmaceuticals (1658551) Subject Klee Justin B. (1898314) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/09/2026 3:36 PM | Amylyx Pharmaceuticals (1658551) Subject FRATES JAMES M (1235598) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/09/2026 3:36 PM | Amylyx Pharmaceuticals (1658551) Subject Cohen Joshua B (1898644) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/05/2026 6:02 AM | Amylyx Pharmaceuticals (1658551) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/05/2026 6:04 AM | Amylyx Pharmaceuticals (1658551) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/07/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer MILNE GEORGE M JR (1179552) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/05/2026 3:38 PM | Amylyx Pharmaceuticals (1658551) Subject MILNE GEORGE M JR (1179552) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/14/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Cohen Joshua B (1898644) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/14/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Klee Justin B. (1898314) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/14/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Mazzariello Gina (1913765) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AMLX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/14/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer FRATES JAMES M (1235598) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/14/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Bedrosian Camille L (1326969) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/11/2026 3:01 PM | Amylyx Pharmaceuticals (1658551) Subject Cohen Joshua B (1898644) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/11/2026 3:01 PM | Amylyx Pharmaceuticals (1658551) Subject Mazzariello Gina (1913765) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/11/2026 3:01 PM | Amylyx Pharmaceuticals (1658551) Subject Bedrosian Camille L (1326969) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/11/2026 3:01 PM | Amylyx Pharmaceuticals (1658551) Subject FRATES JAMES M (1235598) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/11/2026 3:01 PM | Amylyx Pharmaceuticals (1658551) Subject Klee Justin B. (1898314) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/08/2026 3:54 PM | Amylyx Pharmaceuticals (1658551) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/20/2026 8:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Cohen Joshua B (1898644) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2026 8:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Bedrosian Camille L (1326969) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2026 8:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Mazzariello Gina (1913765) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2026 8:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Klee Justin B. (1898314) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2026 8:00 PM | Amylyx Pharmaceuticals (1658551) Issuer FRATES JAMES M (1235598) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2026 4:27 PM | Amylyx Pharmaceuticals (1658551) Filer | Form 424B5 | |
| 08/20/2026 4:28 PM | Amylyx Pharmaceuticals (1658551) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/18/2026 4:17 PM | Amylyx Pharmaceuticals (1658551) Filer | Form 424B5 | |
| 08/18/2026 8:03 AM | Amylyx Pharmaceuticals (1658551) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/18/2026 6:09 AM | Amylyx Pharmaceuticals (1658551) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/06/2026 6:02 AM | Amylyx Pharmaceuticals (1658551) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/06/2026 6:04 AM | Amylyx Pharmaceuticals (1658551) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/13/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Mazzariello Gina (1913765) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/09/2026 3:26 PM | Amylyx Pharmaceuticals (1658551) Subject Mazzariello Gina (1913765) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/08/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer FONTEYNE PAUL R. (1727550) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer MILNE GEORGE M JR (1179552) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Quimi Daphne (1543031) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Firestone Karen (1969821) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Zeiher Bernhardt G (1971421) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 3:06 PM | Amylyx Pharmaceuticals (1658551) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/07/2026 6:02 AM | Amylyx Pharmaceuticals (1658551) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/07/2026 6:04 AM | Amylyx Pharmaceuticals (1658551) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Why I'm selling my Snapback Indicator for just $7 (Ad) For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500.
The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long.
No strings attached, and Wood says there is an unusual reason behind the steep discount. Get lifetime access to the Snapback Indicator for a one-time $7 payment today. |
| 04/23/2026 6:01 AM | Amylyx Pharmaceuticals (1658551) Filer | Form DEF 14A | |
| 04/23/2026 6:02 AM | Amylyx Pharmaceuticals (1658551) Filer | Form DEFA14A | |
| 04/23/2026 6:03 AM | Amylyx Pharmaceuticals (1658551) Filer | Form ARS | |
| 03/26/2026 2:41 PM | Amylyx Pharmaceuticals (1658551) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/24/2026 6:11 AM | Amylyx Pharmaceuticals (1658551) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Bedrosian Camille L (1326969) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Klee Justin B. (1898314) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer FRATES JAMES M (1235598) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Mazzariello Gina (1913765) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 3:00 PM | Amylyx Pharmaceuticals (1658551) Issuer Cohen Joshua B (1898644) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 7:01 AM | Amylyx Pharmaceuticals (1658551) Filer | Form S-3ASR | |
| 03/03/2026 6:02 AM | Amylyx Pharmaceuticals (1658551) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/03/2026 6:10 AM | Amylyx Pharmaceuticals (1658551) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/02/2026 3:30 PM | Amylyx Pharmaceuticals (1658551) Subject Cohen Joshua B (1898644) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 3:30 PM | Amylyx Pharmaceuticals (1658551) Subject Mazzariello Gina (1913765) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 3:30 PM | Amylyx Pharmaceuticals (1658551) Subject FRATES JAMES M (1235598) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 3:30 PM | Amylyx Pharmaceuticals (1658551) Subject Bedrosian Camille L (1326969) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 3:30 PM | Amylyx Pharmaceuticals (1658551) Subject Klee Justin B. (1898314) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/12/2026 8:09 AM | Adage Capital Management, L.P. (1535978) Filed by Amylyx Pharmaceuticals (1658551) Subject | Form SCHEDULE 13G/A | |
| 02/05/2026 12:16 PM | Amylyx Pharmaceuticals (1658551) Subject FMR LLC (315066) Filed by | Form SCHEDULE 13G/A | |
| 02/04/2026 3:05 PM | Amylyx Pharmaceuticals (1658551) Issuer Klee Justin B. (1898314) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 3:05 PM | Amylyx Pharmaceuticals (1658551) Issuer Mazzariello Gina (1913765) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 3:05 PM | Amylyx Pharmaceuticals (1658551) Issuer Cohen Joshua B (1898644) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 3:05 PM | Amylyx Pharmaceuticals (1658551) Issuer FRATES JAMES M (1235598) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 3:10 PM | Amylyx Pharmaceuticals (1658551) Subject FRATES JAMES M (1235598) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/02/2026 3:10 PM | Amylyx Pharmaceuticals (1658551) Subject Klee Justin B. (1898314) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/02/2026 3:10 PM | Amylyx Pharmaceuticals (1658551) Subject Cohen Joshua B (1898644) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/02/2026 3:10 PM | Amylyx Pharmaceuticals (1658551) Subject Mazzariello Gina (1913765) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/20/2026 8:46 PM | Amylyx Pharmaceuticals (1658551) Issuer Klee Justin B. (1898314) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 8:46 PM | Amylyx Pharmaceuticals (1658551) Issuer Cohen Joshua B (1898644) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/15/2026 3:14 PM | Amylyx Pharmaceuticals (1658551) Subject Klee Justin B. (1898314) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/15/2026 3:17 PM | Amylyx Pharmaceuticals (1658551) Subject Cohen Joshua B (1898644) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/14/2026 3:08 PM | Amylyx Pharmaceuticals (1658551) Issuer MILNE GEORGE M JR (1179552) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/08/2026 3:05 PM | Amylyx Pharmaceuticals (1658551) Issuer Cohen Joshua B (1898644) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/08/2026 3:05 PM | Amylyx Pharmaceuticals (1658551) Issuer FRATES JAMES M (1235598) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/08/2026 6:03 AM | Amylyx Pharmaceuticals (1658551) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/06/2026 3:04 PM | Amylyx Pharmaceuticals (1658551) Subject Cohen Joshua B (1898644) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/06/2026 3:05 PM | Amylyx Pharmaceuticals (1658551) Subject Klee Justin B. (1898314) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/06/2026 3:05 PM | Amylyx Pharmaceuticals (1658551) Subject FRATES JAMES M (1235598) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/23/2025 7:48 PM | Amylyx Pharmaceuticals (1658551) Issuer Firestone Karen (1969821) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 4:39 PM | Amylyx Pharmaceuticals (1658551) Subject Commodore Capital LP (1831942) Filed by | Form SCHEDULE 13G | |